Linda Tran, DO
Family Medicine · Exton, PANPI 1942839964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,289, more than ten times the $14 reported in 2020.
Across 142 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$534
- Lilly USA, LLC$345
- Pfizer$306
- AstraZeneca$301
- Novo Nordisk$250
- Astellas Pharma US Inc$193
- plus $615 from 12 others
What the payments were for
- Food & beverage$2,544100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $534 |
| Lilly USA, LLC | 18 | $345 |
| Pfizer | 19 | $306 |
| AstraZeneca | 16 | $301 |
| Novo Nordisk | 15 | $250 |
| Astellas Pharma US Inc | 7 | $193 |
| Amgen | 14 | $157 |
| Sanofi-aventis U.S. LLC | 4 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Exact Sciences | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Dexcom, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Novartis | 1 | $19 |
| Bausch Health US, LLC | 1 | $16 |
| Bavarian Nordic A/s | 1 | $14 |
How this compares
$2,544 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $386 |
| Levothyroxine Sodium | 14 | $199 |
| Amlodipine Besylate | 11 | $154 |
| Rosuvastatin Calcium | 11 | $145 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Exton
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.